Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-114616
Filing Date
2010-05-10
Accepted
2010-05-10 16:16:12
Documents
11
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 819898
2 FORM OF RESTRICTED STOCK UNIT ISSUANCE AGREEMENT dex1029.htm EX-10.29 63042
3 CERTIFICATION OF CEO, AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 8731
4 CERTIFICATION OF CFO, AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 8752
5 CERTIFICATIONS OF CEO AND CFO, AS REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) dex321.htm EX-32.1 4614
  Complete submission text file 0001193125-10-114616.txt   2831979

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gild-20100331.xml EX-101.INS 437674
7 XBRL TAXONOMY EXTENSION SCHEMA gild-20100331.xsd EX-101.SCH 13918
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gild-20100331_cal.xml EX-101.CAL 46498
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gild-20100331_def.xml EX-101.DEF 94216
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gild-20100331_lab.xml EX-101.LAB 96086
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gild-20100331_pre.xml EX-101.PRE 115244
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19731 | Film No.: 10816445
SIC: 2836 Biological Products, (No Diagnostic Substances)